BMY
Price
$46.92
Change
-$0.71 (-1.49%)
Updated
Jul 3 closing price
Capitalization
109.66B
25 days until earnings call
LLY
Price
$780.67
Change
+$1.39 (+0.18%)
Updated
Jul 3 closing price
Capitalization
739.66B
32 days until earnings call
Interact to see
Advertisement

BMY vs LLY

Header iconBMY vs LLY Comparison
Open Charts BMY vs LLYBanner chart's image
Bristol-Myers Squibb
Price$46.92
Change-$0.71 (-1.49%)
Volume$7.02M
Capitalization109.66B
Eli Lilly & Co
Price$780.67
Change+$1.39 (+0.18%)
Volume$1.45M
Capitalization739.66B
BMY vs LLY Comparison Chart in %
Loading...
BMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMY vs. LLY commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMY is a StrongBuy and LLY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (BMY: $46.92 vs. LLY: $780.67)
Brand notoriety: BMY and LLY are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: BMY: 52% vs. LLY: 36%
Market capitalization -- BMY: $109.66B vs. LLY: $739.66B
BMY [@Pharmaceuticals: Major] is valued at $109.66B. LLY’s [@Pharmaceuticals: Major] market capitalization is $739.66B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMY’s FA Score shows that 2 FA rating(s) are green whileLLY’s FA Score has 2 green FA rating(s).

  • BMY’s FA Score: 2 green, 3 red.
  • LLY’s FA Score: 2 green, 3 red.
According to our system of comparison, BMY is a better buy in the long-term than LLY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMY’s TA Score shows that 5 TA indicator(s) are bullish while LLY’s TA Score has 5 bullish TA indicator(s).

  • BMY’s TA Score: 5 bullish, 5 bearish.
  • LLY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both BMY and LLY are a good buy in the short-term.

Price Growth

BMY (@Pharmaceuticals: Major) experienced а +1.91% price change this week, while LLY (@Pharmaceuticals: Major) price change was -1.82% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.13%. For the same industry, the average monthly price growth was +2.56%, and the average quarterly price growth was +9.33%.

Reported Earning Dates

BMY is expected to report earnings on Oct 30, 2025.

LLY is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+1.13% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LLY($740B) has a higher market cap than BMY($110B). LLY has higher P/E ratio than BMY: LLY (131.13) vs BMY (13.73). LLY YTD gains are higher at: 1.505 vs. BMY (-14.101). BMY has higher annual earnings (EBITDA): 19.4B vs. LLY (8.57B). BMY has more cash in the bank: 12.3B vs. LLY (2.93B). LLY has less debt than BMY: LLY (25.2B) vs BMY (41.5B). BMY has higher revenues than LLY: BMY (45B) vs LLY (34.1B).
BMYLLYBMY / LLY
Capitalization110B740B15%
EBITDA19.4B8.57B226%
Gain YTD-14.1011.505-937%
P/E Ratio13.73131.1310%
Revenue45B34.1B132%
Total Cash12.3B2.93B420%
Total Debt41.5B25.2B165%
FUNDAMENTALS RATINGS
BMY vs LLY: Fundamental Ratings
BMY
LLY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
82
Overvalued
PROFIT vs RISK RATING
1..100
10010
SMR RATING
1..100
3015
PRICE GROWTH RATING
1..100
6156
P/E GROWTH RATING
1..100
6296
SEASONALITY SCORE
1..100
55n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMY's Valuation (5) in the Pharmaceuticals Major industry is significantly better than the same rating for LLY (82). This means that BMY’s stock grew significantly faster than LLY’s over the last 12 months.

LLY's Profit vs Risk Rating (10) in the Pharmaceuticals Major industry is significantly better than the same rating for BMY (100). This means that LLY’s stock grew significantly faster than BMY’s over the last 12 months.

LLY's SMR Rating (15) in the Pharmaceuticals Major industry is in the same range as BMY (30). This means that LLY’s stock grew similarly to BMY’s over the last 12 months.

LLY's Price Growth Rating (56) in the Pharmaceuticals Major industry is in the same range as BMY (61). This means that LLY’s stock grew similarly to BMY’s over the last 12 months.

BMY's P/E Growth Rating (62) in the Pharmaceuticals Major industry is somewhat better than the same rating for LLY (96). This means that BMY’s stock grew somewhat faster than LLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMYLLY
RSI
ODDS (%)
Bearish Trend 4 days ago
53%
Bearish Trend 4 days ago
56%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
53%
Bullish Trend 4 days ago
71%
Momentum
ODDS (%)
Bullish Trend 4 days ago
55%
Bearish Trend 4 days ago
53%
MACD
ODDS (%)
Bullish Trend 4 days ago
52%
Bearish Trend 4 days ago
60%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
52%
Bearish Trend 4 days ago
55%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
52%
Bullish Trend 4 days ago
69%
Advances
ODDS (%)
Bullish Trend 13 days ago
54%
Bullish Trend 4 days ago
69%
Declines
ODDS (%)
Bearish Trend 4 days ago
54%
Bearish Trend 17 days ago
52%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
62%
Bearish Trend 4 days ago
39%
Aroon
ODDS (%)
Bullish Trend 4 days ago
51%
Bullish Trend 4 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
BMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GDXU75.900.90
+1.20%
MicroSectors™ Gold Miners 3X Lvrgd ETN
EUO27.580.20
+0.73%
ProShares UltraShort Euro
AVDV80.190.45
+0.56%
Avantis International Small Cap Val ETF
PBFR27.720.11
+0.38%
PGIM Laddered S&P 500 Buffer 20 ETF
FDEV32.470.06
+0.20%
Fidelity International Multifactor ETF

LLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LLY has been loosely correlated with AZN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if LLY jumps, then AZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LLY
1D Price
Change %
LLY100%
+0.18%
AZN - LLY
45%
Loosely correlated
-2.36%
NVS - LLY
42%
Loosely correlated
-1.54%
OGN - LLY
39%
Loosely correlated
-1.87%
MRK - LLY
32%
Poorly correlated
-1.77%
PFE - LLY
32%
Poorly correlated
+0.24%
More